RxDoctor Payments Data

Scott Epstein, MD

Physical Medicine & Rehabilitation · Honesdale, PANPI 1144213646

Payments from drug & device makers

$842in general payments, 2019–2025

Across 57 payments — averaging $14.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Collegium Pharmaceutical, Inc.$465
  • Pfizer$92
  • Daiichi Sankyo Inc.$86
  • Lundbeck LLC$38
  • Amgen$34
  • Biodelivery Sciences International, Inc.$33
  • plus $93 from 4 others

What the payments were for

  • Food & beverage$842100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$842 in reported general payments places this provider in the 75th percentile of 550 physical medicine & rehabilitation providers in Pennsylvania.

See all physical medicine & rehabilitation providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$215,208
Medicare patients
413
Services billed
2,787

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate144$174,405
RelistorMethylnaltrexone Bromide21$47,873
BelbucaBuprenorphine Hcl65$46,213
OxycontinOxycodone Hcl17$31,573
Oxycodone Hcl751$14,925
Fentanyl90$11,344
SuboxoneBuprenorphine Hcl/Naloxone Hcl12$9,540
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen420$8,852
Morphine Sulfate ErMorphine Sulfate243$8,213
EliquisApixaban12$6,388
Buprenorphine22$6,049
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl25$5,399
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen225$5,313
MovantikNaloxegol Oxalate11$4,269
Celecoxib143$2,889

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca$465$220,617209 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor$32$47,87321 claims
PfizerEliquis$92$6,38812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 550 physical medicine & rehabilitation providers in Pennsylvania.

Other physical medicine & rehabilitation in Honesdale

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →